Your colleague now eats only between 12 and 8 and won't stop talking about it. Time to check the receipts.
Intermittent fasting can lower HbA1c in type 2 diabetes, but it hasn't clearly beaten ordinary calorie cutting. In a 12-month trial and a 6-month trial, HbA1c fell similarly with either approach. It suits some people, not all, and anyone on insulin or sulphonylureas needs a doctor's plan because of low-sugar risk.
Last updated: November 2026
The problem
Intermittent fasting (IF) means cycling between eating and not eating. The 5:2 plan cuts calories hard on two days a week; time-restricted eating (TRE) squeezes food into a daily window, such as eight hours. The evidence is calmer than the hype.
What the trials found
The 5:2 trial
In a 12-month trial of 137 adults with type 2 diabetes, HbA1c fell by 0.3% with 5:2 and 0.5% with daily calorie restriction, a difference that met the test for equivalence. Weight loss was 6.8 kg and 5.0 kg (Carter et al., 2018).
The eight-hour window trial
In a six-month trial of 75 adults with type 2 diabetes and obesity, eating only between noon and 8 pm cut weight by 3.56% more than controls. HbA1c fell by 0.91% with TRE and 0.94% with calorie restriction, compared with controls, and the two diets didn't differ (Pavlou et al., 2023).
HBA1C DROP, PERCENTAGE POINTS
5:2 trial, 12 months (change from start)
5:2 fasting
Daily calorie restriction
8-hour window trial, 6 months (vs control)
Time-restricted eating
Daily calorie restriction
Source: Carter et al., 2018; Pavlou et al., 2023. Adults with type 2 diabetes. Trials measured change differently, so compare within each trial.
The bigger picture
A 2024 network meta-analysis pooled 13 studies with 867 people with type 2 diabetes. It found no significant difference between IF styles, and flagged small samples and possible publication bias (Wen et al., 2024). In short: IF works about as well as eating less, mostly because you eat less.
The safety catch
In the 5:2 trial, glucose events in the first two weeks affected 35% of participants using sulphonylureas or insulin (Carter et al., 2018). Long gaps plus glucose-lowering medicines can mean lows.
What to do
- Talk to your doctor first if you take insulin, sulphonylureas or several medicines.
- Pick what you can keep doing. Finishing dinner earlier and skipping the late-night snack is a gentle start.
- Mind what goes in the window. A thali of fried snacks and mithai at noon defeats the point. Use the Indian diabetes plate.
- Track your numbers. Check readings and HbA1c, not just the scale.
- Know when it isn't for you. Ramadan guidance puts pregnancy and poorly controlled type 1 diabetes in the highest-risk group for fasting (IDF-DAR).
Did you know? In the TRE trial, people's daily eating window shrank from almost 12 hours to about 8 hours, and they didn't count calories (Pavlou et al., 2023).
FAQ
Is 16:8 fasting good for type 2 diabetes?
An eight-hour window lowered HbA1c and weight in one six-month trial, about as much as calorie restriction. It can work if it suits you and your doctor agrees.
Is intermittent fasting better than a normal diet for diabetes?
Not clearly. Trials so far show similar HbA1c drops to daily calorie cutting. Choose the approach you can stick with.
Can I fast if I take diabetes medicines?
Only with your doctor's plan. Insulin and sulphonylureas raise the risk of lows during long gaps without food.
Send this to the 16:8 evangelist at work, read our guide to festival fasting with diabetes, and see what HbA1c means.
Research & References
- Carter S, Clifton PM, Keogh JB. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial. JAMA Network Open, 2018. — Supports: HbA1c −0.3% vs −0.5%; weight −6.8 vs −5.0 kg; 35% glucose events on sulphonylureas/insulin.
- Pavlou V, et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Network Open, 2023. — Supports: noon to 8 pm window; weight −3.56%; HbA1c −0.91% vs −0.94%.
- Wen X, Xiao Y, Li L. The effects of different intermittent fasting regimens in people with type 2 diabetes: a network meta-analysis. Frontiers in Nutrition, 2024. — Supports: 13 studies, 867 patients; no significant difference between regimens.
- International Diabetes Federation and DAR International Alliance. Ramadan and Diabetes: Guide to a safe fast. IDF-DAR. — Supports: highest-risk groups for fasting.
This article is for information, not medical advice. If you have diabetes or take medication, talk to your doctor before changing your diet.